Early research (Phase 1)Study completedNCT04799353
What this trial is testing
Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)
Who this might be right for
Human Immunodeficiency Virus (HIV)
AbbVie 33